India Nutraceuticals Market, By Category (Dietary Supplements, Functional Beverages, Functional Foods), By Source (Plants, Animals, Microbial), By Distribution Channel (Pharmacies & Drug Stores, Online, Supermarkets & Hypermarkets, Others), By Sector (Urban, Rural), By Region, Competition, Forecast & Opportunities, 2021-2031F

Market Overview

The India Nutraceuticals Market size accounted for USD 6135.15 Million in 2025 and is predicted to increase from USD 6142.27 Million in 2026 to approximately USD 11769.91 Million by 2031, expanding at a CAGR of 11.47% from 2026 to 2031.

Key Takeaways

• By category, the dietary supplements segment accounted for the largest market share of approximately 43% in 2025, owing to their broad application across nutritional requirements, convenient consumption formats, and availability of products targeting vitamins, minerals, proteins, probiotics, and other wellness needs.
• By source, the plant-based segment held the largest market share of approximately 62% in 2025, supported by strong consumer acceptance of herbal and botanical ingredients, established Ayurveda traditions, and growing preference for naturally derived nutritional products.
• By distribution channel, pharmacies & drug stores emerged as the leading contributor in 2025, supported by established consumer trust, pharmacist recommendations, broad product availability, and the perception of pharmacies as reliable destinations for healthcare and nutritional products.
• By sector, the urban segment accounted for the largest market share of approximately 72% in 2025, driven by greater exposure to health and wellness products, higher availability of organised retail and specialised outlets, and stronger demand for premium and targeted nutritional solutions.
• By region, North India accounted for the largest market share of approximately 34% in 2025, supported by its large consumer base, concentration of major urban centres, established healthcare and retail infrastructure, and strong acceptance of Ayurvedic and herbal products.
• Increasing health and wellness awareness, rising adoption of preventive healthcare, growing demand for functional and plant-based nutrition, expansion of digital commerce, increasing fitness participation, and continued product innovation are expected to drive the long-term growth of the India Nutraceuticals Market.

Market Drivers

Increasing Prevalence of Lifestyle-Related Diseases

The rising burden of lifestyle-related diseases is a key growth driver for India’s nutraceuticals market, as consumers increasingly seek nutritional products to support preventive health and long-term disease management. According to the ICMR-INDIAB study, which covered 113,106 individuals across 30 states and Union Territories, 9.6% of India’s population has diabetes, highlighting the substantial demand for products supporting metabolic health. Furthermore, WHO estimates that 49.1% of deaths in India were attributable to noncommunicable diseases in 2021, while cardiovascular disease affects approximately 45% of people aged 40–69 years. Increasing prevalence of diabetes, cardiovascular disorders, obesity and hypertension is therefore encouraging consumers to adopt supplements containing vitamins, minerals, omega-3, probiotics and other functional ingredients as part of preventive wellness routines.

Growing Adoption of Preventive Healthcare

Growing emphasis on preventive healthcare is strengthening demand for nutraceuticals in India, as consumers increasingly seek products that support immunity, nutrition, healthy ageing and long-term wellness. Government initiatives are also expanding awareness and access to preventive services. During the Ayushman Bhav campaign, 34.39 crore people underwent screening for seven diseases, including diabetes and hypertension, while 16.96 lakh wellness, yoga and meditation sessions were conducted as of March 2024. In addition, the latest National Programme for Prevention and Control of NCDs reports 74.97 crore beneficiaries enrolled and 8.64 crore patients under treatment for hypertension and diabetes, indicating the scale of India’s preventive-health ecosystem. This growing health consciousness is expected to encourage regular consumption of vitamins, minerals, probiotics, omega-3 and other nutritional supplements.

Expansion of E-Commerce and Digital Health Platforms

Rapid expansion of India’s digital infrastructure is improving access to nutraceuticals beyond major metropolitan markets and supporting the shift toward online purchasing. As of March 2026, India had approximately 1.09 billion internet subscribers and 1.07 billion broadband subscribers, providing a substantial digital consumer base for online health and wellness platforms. In addition, UPI processed 24,161.69 crore transactions worth ₹314 lakh crore during FY2025–26, with UPI accounting for 85% of India’s digital-payment volume, facilitating convenient online purchases. Government data also indicates that India’s e-commerce market is projected to reach USD 163 billion by 2026, with tier-2 and tier-3 cities emerging as important growth markets. These developments are expanding product availability, consumer choice and convenience, thereby supporting nutraceutical adoption.

Download Free Sample Report

Market Restraints

Regulatory Uncertainty and Compliance Complexity

India’s nutraceutical industry operates within a regulatory framework that spans multiple product categories, including health supplements, nutraceuticals, probiotics, prebiotics and novel foods. FSSAI’s framework requires manufacturers to comply with specific ingredient, labelling, safety and claims requirements. The overlap between food and pharmaceutical classifications can further create uncertainty, particularly for products positioned around therapeutic benefits. A recent academic review also highlights ambiguity in product categorisation and the need for stronger regulatory oversight. These complexities can increase compliance expenditure, delay product launches and create challenges for smaller manufacturers with limited regulatory resources.

Limited Clinical Evidence Supporting Health Claims

A significant restraint is the limited availability of robust clinical evidence supporting the efficacy of many nutraceutical formulations. Unlike pharmaceuticals, nutraceuticals generally do not undergo equivalent levels of clinical testing before reaching consumers. Research has highlighted gaps in clinical evidence, standardisation of dosage and post-market safety monitoring. This can make it difficult for manufacturers to substantiate differentiated health claims and may reduce confidence among healthcare professionals and consumers. FSSAI regulations also restrict products from claiming to treat, cure, mitigate or prevent specific diseases unless specifically permitted, limiting the extent to which manufacturers can communicate therapeutic benefits.

Product Quality and Adulteration Concerns

Variations in raw-material quality, manufacturing standards and formulation consistency can constrain consumer trust in nutraceutical products. Academic research has identified concerns regarding adulterated, spurious and low-quality ingredients within the sector, alongside insufficient evidence regarding the safety and efficacy of some products. Such concerns can discourage repeat purchases and make consumers more dependent on established brands, thereby increasing the barriers to entry for smaller companies. Maintaining consistent ingredient purity and formulation quality also increases testing and manufacturing costs.

Market Opportunities

Export of Ayurveda-Based Nutraceuticals

The internationalisation of Ayurveda presents a significant opportunity for Indian nutraceutical manufacturers to transition from commodity-oriented exports toward higher-value, branded finished products. According to NITI Aayog’s 2026 Strategic Roadmap for Making Ayurveda Global, Ayurvedic products are currently exported to around 150 countries, primarily as dietary supplements and wellness products. India’s Ayush exports increased from USD 1.09 billion in 2014 to USD 2.16 billion in 2023, demonstrating substantial international market potential. The report also highlights the need to increase the share of finished products and diversify into markets across Asia, Africa and Latin America. This creates opportunities for Indian companies to develop standardised, export-compliant nutraceutical formulations, strengthen international branding and capture greater value from India’s established Ayurveda heritage.

Expansion into Functional Foods and Beverages

Expansion into functional foods and beverages presents a significant opportunity for Indian nutraceutical companies to diversify beyond conventional capsules and tablets into fortified beverages, nutrition bars, functional snacks, ready-to-eat products and meal replacements. India’s strong agricultural base provides a broad raw-material pool for such innovation, with millet production reaching approximately 18.59 million tonnes in 2024–25. Government support is further encouraging value-added food manufacturing; ₹793.27 crore has been approved under the ₹800-crore PLI scheme for millet-based products, supporting 29 companies. Moreover, millet-based product sales under the scheme increased from ₹35 crore in FY2020–21 to ₹814 crore in FY2024–25, demonstrating commercial potential. This creates opportunities for innovative, convenient and culturally relevant functional nutrition formats.

Global Market Expansion Through Free Trade Agreements

India’s expanding network of Free Trade Agreements (FTAs) creates an opportunity for nutraceutical manufacturers to access international markets through preferential tariffs, regulatory cooperation and streamlined export procedures. As of 2026, India had nine FTAs covering 38 countries, with recent agreements including the UK, Oman, New Zealand and the European Union. The Government has specifically identified nutraceuticals, herbal extracts and medicinal plants as products that can benefit from improved market access under these agreements. Notably, India’s FTA with New Zealand includes a dedicated chapter on Health and Traditional Medicine, creating a structured pathway for AYUSH-related products. These developments provide Indian nutraceutical companies with opportunities to diversify export destinations, establish international partnerships and develop market-specific formulations for overseas consumers.

Market Trends

Shift Toward Convenient and Consumer-Friendly Formats

India’s nutraceutical market is increasingly moving beyond conventional tablets and capsules toward gummies, chewables, powders, granules, sachets, effervescent formats, mouth-dissolving strips and ready-to-consume products. This trend reflects manufacturers’ efforts to improve palatability, portability and ease of consumption while making supplementation more compatible with everyday routines. FSSAI’s current regulatory framework explicitly permits a broad range of delivery formats, including powders, tablets, capsules, liquids, gummies, jellies, chewables, mouth-dissolving strips, bars, biscuits and candies. The regulatory recognition of these formats is encouraging companies to experiment with differentiated product presentations and target specific consumer preferences. Consequently, format innovation is becoming an important competitive element, particularly as brands seek to improve consumer experience and differentiate products within increasingly crowded nutraceutical categories.

Increasing Focus on Gut Health and Microbiome Nutrition

Gut health is emerging as a distinct product-development trend within India’s nutraceutical market, with manufacturers increasingly exploring probiotics, prebiotics, synbiotics, digestive enzymes and fibre-based formulations. The focus is shifting from general digestive support toward products positioned around microbiome balance and broader nutritional wellness. FSSAI formally recognises probiotic and prebiotic foods as separate categories within its nutraceutical regulatory framework, providing a defined basis for product development. FSSAI’s framework specifies that probiotic products should deliver at least 10⁸ CFU in the recommended daily serving, while requiring declaration of the probiotic strain and viable count at the end of shelf life. These requirements are encouraging greater emphasis on strain selection, product stability, dosage precision and scientifically substantiated formulations, while supporting increasing differentiation within the gut-health segment.

Expansion of Clean-Label and “Free-From” Formulations

Clean-label positioning is becoming increasingly prominent in India’s nutraceutical market, with consumers showing greater interest in natural, minimally processed and preservative-free formulations and clearer ingredient information. A 2025 consumer study covering approximately 6,000 Indians found that 55% of respondents actively sought snacks containing natural, preservative-free ingredients, indicating growing preference for simpler product compositions. This trend is also encouraging manufacturers to emphasise ingredient sourcing, formulation transparency and easily recognisable components on product packaging. FSSAI’s regulatory framework requires nutraceutical products to comply with specified labelling requirements and restricts unsupported health claims, reinforcing the importance of transparent product communication. Consequently, brands are increasingly using attributes such as plant-based, sugar-free and preservative-free positioning to differentiate products and appeal to consumers seeking greater control over what they consume.

Market Report Coverage and Key Metrics

Market Segmentation Analysis

By Category Insights

Why Did Dietary Supplements Secure the Largest Share of the India Nutraceuticals Market?

Dietary supplements are estimated to account for approximately 43% of the India nutraceuticals market, supported by their broad applicability across consumer groups and health requirements. The segment benefits from a diverse product portfolio encompassing vitamins, minerals, proteins, omega-3, probiotics and botanical supplements, enabling manufacturers to address multiple nutritional needs within a single category. Convenient dosage forms, established consumer familiarity and relatively straightforward integration into daily routines further strengthen adoption. The availability of products across pharmacies, supermarkets, specialist retailers and digital platforms also supports widespread accessibility. In addition, dietary supplements offer greater formulation flexibility, allowing brands to develop products targeting specific nutritional requirements, age groups and wellness objectives. Their combination of versatility, accessibility and recurring-use potential positions dietary supplements as the leading product segment.

By Source Insights

Why Did Plants Dominate the India Nutraceuticals Market?

Plant-based sources are estimated to account for approximately 62% of the India nutraceuticals market by source, supported by their broad availability, diverse bioactive compounds and strong alignment with established dietary preferences. India’s longstanding familiarity with Ayurveda and botanical ingredients creates greater acceptance of plant-derived formulations, particularly herbal supplements and botanical extracts. Plant sources also offer extensive formulation flexibility, enabling manufacturers to address varied wellness requirements through ingredients such as herbs, spices, fruits, vegetables and other botanicals. Their compatibility with vegetarian and plant-centric consumption patterns further broadens their addressable consumer base. In addition, the availability of numerous indigenous medicinal plants provides manufacturers with a diverse ingredient base for developing differentiated formulations. These factors collectively support the dominance of plant-based sources in India’s nutraceuticals market.

By Distribution Channel Insights

Why Did Pharmacies & Drug Stores Dominate the India Nutraceuticals Market?

Pharmacies and drug stores are estimated to account for approximately 34% of the India nutraceuticals market, supported by their strong association with healthcare, established consumer trust and convenient access to health-related products. Consumers often perceive pharmacy-based nutraceuticals as more credible because these outlets provide opportunities for pharmacist guidance and product recommendations, particularly for vitamins, minerals and condition-specific supplements. Pharmacies also offer a broad assortment of established brands and dosage formats, enabling consumers to compare products within a healthcare-oriented retail environment. Their established procurement and distribution networks further support consistent product availability across locations. In addition, nutraceuticals can be purchased alongside medicines and other healthcare products, making pharmacies a convenient one-stop destination and reinforcing their position as a leading distribution channel.

By Sector Insights

Why Did Urban Sector Dominate the India Nutraceuticals Market?

The urban sector is estimated to account for approximately 72% of the India nutraceuticals market, supported by stronger consumer exposure to health and wellness products, higher concentration of organised retail, and greater availability of specialised nutraceutical brands. Urban consumers are more likely to seek convenient, targeted and premium nutritional products suited to fast-paced lifestyles, including protein supplements, vitamins, probiotics and functional beverages. Greater access to pharmacies, supermarkets, fitness centres and digital commerce also facilitates product discovery and purchase. In addition, urban consumers typically have greater exposure to nutrition-focused content, professional health advice and evolving wellness trends, supporting experimentation with newer product categories. The concentration of affluent and health-conscious consumer segments in metropolitan areas further reinforces the urban sector’s leading position.

Download Free Sample Report

Market Regional Analysis: South India, North India, West India, East India

Why Did North India Lead the India Nutraceuticals Market?

North India is estimated to account for approximately 34% of the India nutraceuticals market, supported by its large consumer base, concentration of major urban centres and well-established healthcare and retail infrastructure. The region benefits from strong demand across Delhi NCR, Uttar Pradesh, Haryana, Punjab, Rajasthan and Chandigarh, where consumers have greater access to pharmacies, organised retail, fitness centres and branded wellness products. A strong cultural familiarity with Ayurveda and herbal products also supports acceptance of plant-based nutraceuticals. In addition, the concentration of affluent and professionally employed consumers in major northern cities encourages spending on premium nutrition and wellness products. Established distribution networks and growing availability of specialised nutraceutical brands further reinforce North India’s leading regional position.

Why Is South India Expected to Register the Fastest Growth in the India Nutraceuticals Market?

South India is expected to register the fastest growth in the India nutraceuticals market, supported by increasing consumer interest in preventive wellness, fitness and specialised nutrition. The region’s growing base of urban, digitally engaged and health-conscious consumers is encouraging adoption of premium and targeted nutraceutical products. Strong presence of healthcare institutions, pharmacies, fitness centres, modern retail and technology-enabled businesses provides an enabling ecosystem for product awareness and distribution. The region also has high acceptance of Ayurvedic, herbal and plant-based formulations, supporting demand for naturally derived nutraceuticals. In addition, expanding lifestyle-oriented consumer segments are creating opportunities for sports nutrition, functional foods, probiotics and personalised supplementation. Greater penetration into emerging urban centres across the region is expected to further accelerate market expansion.

Key Market Players

• Haleon Plc.
• Dabur India Limited
• Abbott India Limited
• Bayer India Limited
• Merck India Limited
• Himalaya Wellness Company
• Amway India
• Baidyanath Group
• Wockhardt Limited
• Herbalife
• Neuherbs
• Pure Nutrition

Recent Developments

In August 2026, the Government began consultations on a potential incentive framework for the nutraceutical industry, aimed at strengthening domestic manufacturing and export capabilities. The initiative involves the Ministry of Food Processing Industries, Ministry of Health and FSSAI.

 FSSAI has intensified scrutiny of nutraceutical manufacturing facilities and product claims. In July 2026, it suspended Rehaan Healthcare’s licence after identifying serious manufacturing and hygiene deficiencies, while additional actions were taken against companies over misleading product claims.

Abbott launched Ensure Strength Pro in India in May 2026, containing 31 nutrients and 30 grams of protein, specifically targeting healthy ageing and multiple aspects of nutritional wellbeing.

Report Scope:

By Category

• Dietary Supplements
• Functional Beverages
• Functional Foods

By Source

• Plants
• Animals
• Microbial

By Distribution Channel

• Pharmacies & Drug Stores
• Online
• Supermarkets & Hypermarkets
• Others

By Sector

• Urban
• Rural

By Region

• South India
• North India
• West India
• East India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the India Nutraceuticals Market.

Available Customizations:

India Nutraceuticals market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information